We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Moderna
MRNA
$21.6B
| $4.18M | 0.01% |
35,200
+26,300
| +296% | +$3.33M |
|
1052
Crown Castle
CCI
$34.6B
| $4.17M | 0.01% |
42,726
-14,174
| -25% | -$1.4M |
|
1053
Corning
GLW
$107B
| $4.16M | 0.01% |
107,046
-16,486
| -13% | -$576K |
|
1054
Truist Financial
TFC
$63.9B
| $4.14M | 0.01% |
106,680
-480,125
| -82% | -$18.1M |
|
|
1055
CALL
Micron Technology
MU
$835B
| $4.14M | 0.01% |
31,500
+22,600
| +254% | +$2.85M |
|
1056
Core Scientific
CORZ
$5.79B
| $4.14M | 0.01% |
444,983
+329,385
| +285% | +$1.68M |
|
|
NVEI
1057
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $4.14M | 0.01% |
127,800
-77,112
| -38% | -$2.48M |
|
1058
Ascendis Pharma A/S
ASND
$16.5B
| $4.13M | 0.01% |
30,289
+5,205
| +21% | +$708K |
|
1059
Smith & Wesson
SWBI
$649M
| $4.13M | 0.01% |
+287,907
| New | +$4.73M |
|
|
MREO
1060
Mereo BioPharma
MREO
$48.9M
| $4.12M | 0.01% |
+1,144,051
| New | +$3.71M |
|
1061
Jack Henry & Associates
JKHY
$11.4B
| $4.1M | 0.01% |
24,698
-265,436
| -91% | -$44.1M |
|
1062
TaskUs
TASK
$594M
| $4.1M | 0.01% |
307,969
-78,445
| -20% | -$1.01M |
|
1063
STAG Industrial
STAG
$7.44B
| $4.09M | 0.01% |
+113,530
| New | +$4.04M |
|
1064
Tanger
SKT
$4.78B
| $4.09M | 0.01% |
150,822
-231,216
| -61% | -$6.36M |
|
1065
Vaalco Energy
EGY
$562M
| $4.08M | 0.01% |
650,966
-19,575
| -3% | -$126K |
|
1066
UiPath
PATH
$6.52B
| $4.08M | 0.01% |
321,525
-318,096
| -50% | -$5.5M |
|
1067
Scholar Rock
SRRK
$5.88B
| $4.06M | 0.01% |
487,285
+444,961
| +1,051% | +$5.44M |
|
|
SRCL
1068
DELISTED
Stericycle Inc
SRCL
| $4.05M | 0.01% |
+69,641
| New | +$3.58M |
|
1069
Riot Platforms
RIOT
$6.9B
| $4.04M | 0.01% |
441,824
+321,061
| +266% | +$3.24M |
|
1070
RingCentral
RNG
$4.83B
| $4.04M | 0.01% |
143,128
-30,645
| -18% | -$986K |
|
|
KEEL
1071
Keel Infrastructure Corp
KEEL
$1.92B
| $4.02M | 0.01% |
+1,562,471
| New | +$3.36M |
|
1072
First Solar
FSLR
$21.4B
| $4.01M | 0.01% |
17,800
-196,456
| -92% | -$42.8M |
|
1073
Greif
GEF
$4.95B
| $4.01M | 0.01% |
+69,806
| New | +$4.41M |
|
1074
EVgo
EVGO
$219M
| $4M | 0.01% |
1,633,304
+651,475
| +66% | +$1.34M |
|
|
AZPN
1075
DELISTED
Aspen Technology Inc
AZPN
| $3.99M | 0.01% |
+20,093
| New | +$4.13M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.